Cargando…

Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review

Pregnancy is a medical condition in which the physiological changes in the maternal body and the potential impact on the developing fetus require a cautious approach in terms of drug administration. Individual treatment, a thorough assessment of the extent of the disease, and a broad knowledge of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Demarinis, Giuseppe, Tatti, Filippo, Taloni, Andrea, Giugliano, Antonio Valentino, Panthagani, Jesse, Myerscough, James, Peiretti, Enrico, Giannaccare, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610321/
https://www.ncbi.nlm.nih.gov/pubmed/37895903
http://dx.doi.org/10.3390/ph16101433
_version_ 1785128226613362688
author Demarinis, Giuseppe
Tatti, Filippo
Taloni, Andrea
Giugliano, Antonio Valentino
Panthagani, Jesse
Myerscough, James
Peiretti, Enrico
Giannaccare, Giuseppe
author_facet Demarinis, Giuseppe
Tatti, Filippo
Taloni, Andrea
Giugliano, Antonio Valentino
Panthagani, Jesse
Myerscough, James
Peiretti, Enrico
Giannaccare, Giuseppe
author_sort Demarinis, Giuseppe
collection PubMed
description Pregnancy is a medical condition in which the physiological changes in the maternal body and the potential impact on the developing fetus require a cautious approach in terms of drug administration. Individual treatment, a thorough assessment of the extent of the disease, and a broad knowledge of the therapeutic options and different routes of administration of ophthalmic drugs are essential to ensure the best possible results while minimizing risks. Although there are currently several routes of administration of drugs for the treatment of eye diseases, even with topical administration, there is a certain amount of systemic absorption that must be taken into account. Despite continuous developments and advances in ophthalmic drugs, no updated data are available on their safety profile in these contexts. The purpose of this review is both to summarize the current information on the safety of ophthalmic treatments during pregnancy and lactation and to provide a practical guide to the ophthalmologist for the treatment of eye diseases while minimizing harm to the developing fetus and addressing maternal health needs.
format Online
Article
Text
id pubmed-10610321
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106103212023-10-28 Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review Demarinis, Giuseppe Tatti, Filippo Taloni, Andrea Giugliano, Antonio Valentino Panthagani, Jesse Myerscough, James Peiretti, Enrico Giannaccare, Giuseppe Pharmaceuticals (Basel) Review Pregnancy is a medical condition in which the physiological changes in the maternal body and the potential impact on the developing fetus require a cautious approach in terms of drug administration. Individual treatment, a thorough assessment of the extent of the disease, and a broad knowledge of the therapeutic options and different routes of administration of ophthalmic drugs are essential to ensure the best possible results while minimizing risks. Although there are currently several routes of administration of drugs for the treatment of eye diseases, even with topical administration, there is a certain amount of systemic absorption that must be taken into account. Despite continuous developments and advances in ophthalmic drugs, no updated data are available on their safety profile in these contexts. The purpose of this review is both to summarize the current information on the safety of ophthalmic treatments during pregnancy and lactation and to provide a practical guide to the ophthalmologist for the treatment of eye diseases while minimizing harm to the developing fetus and addressing maternal health needs. MDPI 2023-10-09 /pmc/articles/PMC10610321/ /pubmed/37895903 http://dx.doi.org/10.3390/ph16101433 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Demarinis, Giuseppe
Tatti, Filippo
Taloni, Andrea
Giugliano, Antonio Valentino
Panthagani, Jesse
Myerscough, James
Peiretti, Enrico
Giannaccare, Giuseppe
Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review
title Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review
title_full Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review
title_fullStr Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review
title_full_unstemmed Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review
title_short Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review
title_sort treatments for ocular diseases in pregnancy and breastfeeding: a narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610321/
https://www.ncbi.nlm.nih.gov/pubmed/37895903
http://dx.doi.org/10.3390/ph16101433
work_keys_str_mv AT demarinisgiuseppe treatmentsforoculardiseasesinpregnancyandbreastfeedinganarrativereview
AT tattifilippo treatmentsforoculardiseasesinpregnancyandbreastfeedinganarrativereview
AT taloniandrea treatmentsforoculardiseasesinpregnancyandbreastfeedinganarrativereview
AT giuglianoantoniovalentino treatmentsforoculardiseasesinpregnancyandbreastfeedinganarrativereview
AT panthaganijesse treatmentsforoculardiseasesinpregnancyandbreastfeedinganarrativereview
AT myerscoughjames treatmentsforoculardiseasesinpregnancyandbreastfeedinganarrativereview
AT peirettienrico treatmentsforoculardiseasesinpregnancyandbreastfeedinganarrativereview
AT giannaccaregiuseppe treatmentsforoculardiseasesinpregnancyandbreastfeedinganarrativereview